Israel’s PatenSee (see here previously) has received US FDA Breakthrough Device Designation for its non-contact vascular access (VA) management technology designed for patients undergoing hemodialysis. Its imaging & AI warns of fistula deterioration.
Breakthrough device for dialysis patients
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.